NDSS CGM Subsidy Initiative - AMSL Diabetes

NDSS CGM Subsidy Initiative

About the Continuous Glucose Monitoring (CGM) Subsidy Initiative

The Australian Government provides access for eligible people with Type 1 diabetes to FULLY SUBSIDISED Dexcom CGM through the CGM Initiative as part of the NDSS. Subsidised access to Dexcom CGM products is available through the NDSS for eligible people only.

Already receiving Dexcom G5 Mobile CGM through the NDSS Subsidy and using the t:slim X2 insulin pump?
Find out how you can switch to Dexcom G6!


To be eligible to access the NDSS CGM Subsidy Initiative, you must be assessed by an authorised healthcare professional and meet the criteria for one of the following groups:   

The eligibility criteria for each group is available on the NDSS. Talk to your healthcare professional to further discuss the eligibility criteria.

What are the steps to access Dexcom CGM through the NDSS Subsidy Initiative (if you have been confirmed eligible)?

  1. An authorised healthcare professional will be able to assess your eligibility for the CGM Subsidy Initiative and you will then need to complete the CGM NDSS Order Form available here (Temporary update: To make things easier during COVID-19 pandemic, only your healthcare professional needs to complete the form and you will not be required to co-sign) 
  2. Once you complete the form, NDSS will be able to confirm and certify your eligibility
  3. Once the NDSS confirms your eligibility, you will then be sent information on ordering your Dexcom CGM system through your local NDSS Pharmacy/Access Point

Dexcom G5 Mobile CGM systems are available to eligible patients who meet the above criteria.

In addition, as of 18th January 2021, if you are using a Tandem t:slim X2™ insulin pump and meet the criteria above you can now have access to the NEW Dexcom G6 CGM.

For more information on the full eligibility criteria please visit the NDSS website found here. As of the 18th January 2021, updated Continuous Glucose Monitoring Access Forms will be available on the NDSS website found here.

Find more information about continuous glucose monitoring can be found on our website here or alternatively, on the NDSS website here.

About Dexcom CGM:

By using a CGM platform, such as Dexcom G6 or Dexcom G5 Mobile studies indicate significantly improved HbA1c and lessened risk of hypoglycaemia.1,2,3,4

CGM provides dynamic glucose information by showing where your glucose is, where it’s going, and how fast it’s getting there. Better yet, with Dexcom G6, there are no fingerpricks* and no scanning required, for daily glucose management decisions.

AMSL Diabetes distribute both Dexcom G6 and Dexcom G5 Mobile systems, which are available for subsidised access. Refer to the table below to compare the differences between Dexcom G6 and Dexcom G5 Mobile CGM systems.


Switching Over:

Already on the CGM Subsidy Initiative but wanting to switch to Dexcom CGM?
Eligible NDSS registrants are able to switch from another subsidised device/product to Dexcom G5 Mobile. Your healthcare professional will be able to submit a switch form on your behalf to the NDSS. You can find the switching (updating access) form here to take to your next appointment with your healthcare professional. It’s that easy!

If you are using the t:slim X2 insulin pump and are eligible under the NDSS CGM Subsidy Initiative, you can also access/switch to the Dexcom G6 CGM.

Always read the label and use only as directed. Read the warnings available on amsldiabetes.com.au/resources before purchasing. Consult your healthcare professional to see which product is right for you.

How do I switch from the Dexcom G5 Mobile to the Dexcom G6 if I have a t:slim X2 insulin pump?

If you are already receiving the Dexcom G5 Mobile products through the NDSS Subsidy Initiative and would like to switch to the Dexcom G6, you will need to complete the ‘Update or Cease Access’ Form found here, once updated as of the 18th January 2021.  For more information on this process, please visit the NDSS website or contact NDSS directly.

References: 1.Šoupal J, Petruželková L, Flekač M et al. Comparison of Different Treatment Modalities for Type 1 Diabetes, Including Sensor-Augmented Insulin Regimens, in 52 Weeks of Follow-Up: A COMISAIR Study. Diabetes Technol Ther. 2016;18(9):532-538. doi:10.1089/dia.2016.0171. 2. Welsh J, Gao P, Derdzinski M et al. Accuracy, Utilization, and Effectiveness Comparisons of Different Continuous Glucose Monitoring Systems. Diabetes Technol Ther. 2019;21(3):128-132. doi:10.1089/dia.2018.0374. 3. Bailey, Chang, Christiansen Clinical Accuracy of a Continuous Glucose Monitoring System with an Advanced Algorithm J Diabetes Sc Tech 2015 Vol 9(2) 209-214. 4. Laffel Improved Accuracy of Continuous Glucose Monitoring Systems in Pediatric Patients with Diabetes Mellitus – Results from Two Studies Diabetes Technology & Therapeutics Volume 18, Supplement 2, 2016. 5. Data on file.
The Dexcom G6 is only compatible with the t:slim X2 insulin pump with Basal-IQ™ Technology. For more information on how to upgrade your existing pump, please contact us. If your glucose alerts and readings do not match your symptoms or expectations or you are taking medications containing paracetamol/acetaminophen, you should obtain a fingerprick to confirm your blood glucose level.* A fingerprick is needed every 12 hours for the Dexcom G5 Mobile to calibrate and twice in the first 2 hours. Dexcom G6 readings can be used to make diabetes treatment decisions when taking up to a maximum paracetamol dose of 1,000mg every 6 hours. Taking a higher dose may affect readings. Δ The Dexcom G5 Mobile or Dexcom  G6  CGM Transmitter can only be paired with one medical device (either a Dexcom Receiver or the t:slim X2 insulin pump) and one compatible mobile device (phone or tablet) at the same time. Smart device and Receiver not included with Dexcom G5 Mobile or Dexcom G6 CGM system. To view a list of compatible smart devices, visit dexcom.com/compatibility. ^ The latest Basal-IQ technology update is not compatible with Dexcom G5 Mobile. Dexcom G6 is only compatible with t:slim X2 insulin pump with Basal-IQ technology. To have subsidised Dexcom G6 CGM system, you would need to be using a t:slim X2 insulin pump with Basal-IQ technology and meet the NDSS’s eligibility criteria. Sale or distribution for the t:slim X2 insulin pump is not currently available. Requires the Dexcom Follow App and an internet connection. Followers should always confirm readings on the Dexcom G5 Mobile App, Dexcom G6 App or Receiver before making treatment decisions. § Compatible with Dexcom, t:slim X2 insulin pump and commercially available glucose meters. When compared to Dexcom G5. Dexcom, Dexcom G6, Dexcom G5 Mobile, Dexcom G4 PLATINUM, Dexcom Share, Dexcom Follow and Dexcom CLARITY are registered trademarks of Dexcom, Inc. in the United States and/or other countries.

NDSS CGM Subsidy Initiative

Stay informed with AMSL Diabetes

Now you can get all the latest news and updates of our products, events and resources right into your inbox.

Something went wrong. Please try again later!

Send AMSL Diabetes a message

We are always happy to help, send us a message or enquiry

Back to top